Category : Search result: UBA shares


Kaduna Mega Poultry Project to Create 350,000 Jobs

Kaduna State's $200 million Mega Poultry Project is set to generate $450 million in annual revenue and over 350,000 jobs, boosting food security and agribusiness. Read more on this transformative initiative.

NGX Lists 3.16 Billion New UBA Shares

The Nigerian Exchange has listed 3.16 billion new UBA shares from a rights issue, raising N158bn and pushing the bank's total capital above the CBN's N500bn requirement. Read more.

Agro-firm Lists N1.09bn Shares on NGX

Zichis Agro-allied Industries Plc lists N1.09 billion shares on the Nigerian Exchange. The move marks its transition to a public company, with a commitment to strong governance and investor value.

Late Brig. Gen. Uba, 8 Soldiers Get National Awards

President Tinubu's government has honoured late Brigadier General Musa Uba and eight other Nigerian Army personnel for gallantry and service. Read about the awards and new initiatives to honour heroes.

Kaduna Clarifies Victor Solomon Death Sentence Ruling

Kaduna State Government clarifies the lawful conviction of Victor Solomon, debunking social media misinformation. Learn the facts behind the two separate court cases and the state's commitment to due process.

Experts Question Repeal of 2024, 2025 Budget Acts

Economist Chiwuike Uba critiques the Budget Office's justification for repealing and re-enacting the 2024 and 2025 budgets, highlighting constitutional and transparency issues. Read the full analysis.

UBA Exceeds CBN Capital Requirement with N157.84bn Rights Issue

United Bank for Africa (UBA) has successfully raised N157.84 billion through a rights issue, exceeding the Central Bank of Nigeria's N500 billion minimum capital requirement. The offer was oversubscribed by 113%, demonstrating strong investor confidence.

UBA Beats CBN's N500bn Capital Target Early

United Bank for Africa (UBA) has officially exceeded the Central Bank's N500bn capital requirement for international banks. The feat, achieved via a N178.3bn rights issue, positions UBA for expansion ahead of the March 2026 deadline. Read the full details

CBN Issues New Cash Directive to Banks for 2026

The Central Bank of Nigeria has directed commercial banks to guarantee steady cash flow in ATMs and branches nationwide. This follows a successful festive season with minimal scarcity.

Kaduna's 2027 Power Play: Key Brokers and Strategies

Ahead of 2027, Kaduna State becomes a political battleground. Governor Uba Sani, ex-governors El-Rufai and Makarfi, and insecurity shape the race. Will APC hold or will ADC's new alliance disrupt?

Nigeria's Healthcare and Education in Crisis

Nigeria's healthcare and education systems face severe neglect, with fewer than 35,000 doctors for 200 million people. Explore the impact of insecurity and the resilience of Nigerians. Read more.

Banks to Charge N50 Stamp Duty from Jan 1, 2026

Nigerian banks will implement a N50 stamp duty levy on electronic transfers of N10,000 and above starting January 1, 2026. Learn what's changing and which transactions are exempt.

N50 Stamp Duty on Bank Transfers Starts 2026

From January 1, 2026, Nigerian banks will charge senders a N50 stamp duty on electronic transfers of N10,000 and above. Learn about the new levy and other CBN-approved charges.

Kaduna 2026 Budget: N100m Allocated to Each Ward

Kaduna State's 2026 budget allocates N100m to each of its 255 wards for grassroots projects. Education receives the largest share at 25% of the N985.9bn budget. Read details of the historic plan.

Elumelu's $50 Gift to Okocha Trends Online

Nollywood actor Charles Okocha's dramatic reaction to a $50 Christmas gift from billionaire Tony Elumelu has gone viral, sparking mixed reactions from fans online.

Cousin Kills Man Over Phone Charger in Anambra

A 20-year-old man, Chisom Uba, was stabbed to death by his cousin during an argument over a phone charger in Ihiala, Anambra. The victim's uncle also participated in the attack. Read the full story.

Pfizer Shares Fall on Weak 2026 Profit Outlook

Pfizer shares tumbled after the drugmaker projected flat revenues and lower profits for 2026, citing declining Covid-19 sales and heavy investment in new products like weight-loss drugs.

Page 1 of 3